Quest Diagnostics Campaign Challenges Colorectal Cancer Screening ...(ide leader in cancer diagnostics we take...)

Date:3/31/2008

ide leader in cancer diagnostics, we take seriously our role in patient compliance with annual colorectal cancer screening. Our Challenge is designed to encourage people 50 and over and those at risk to complete annual screening with American Cancer Society (ACS) recommended tests, such as the FDA approved, InSure FIT(TM) test and its painless, non-invasive Blue-Brush Method."

Fecal occult blood tests (FOBTs), including the newer fecal immunochemical tests (FITs), detect blood in the stool that might indicate colorectal cancer or other lower gastrointestinal diseases. These screening tests help identify individuals that are candidates for colonoscopy, even if they do not have overt symptoms of colorectal cancer. This may mean the disease is in its early, more treatable stages, or that they may have precancerous polyps that can be removed during colonoscopy.

The Challenge urges individuals to talk to their healthcare providers about annual colorectal cancer screening using the InSure(R) FIT(TM) take-home test, and in turn, to challenge friends and family members to "have the guts" to get screened, too. A newly created Challenge website, http://www.DoYouHaveTheGuts.com, offers tools to learn about FIT testing and the urgency of colorectal cancer screening, as well as a forum to share individual experiences with screening. Challenge participants can also send an attention-grabbing "Happy, Healthy Colon" e-card to loved ones as a reminder to get screened annually. Medical professionals can access the latest scientific data on InSure FIT, up-to-date colorectal cancer screening guidelines and resources, and patient education materials that can help guide discussions with their patients about colorectal cancer screening.

Medical experts advise that anyone at age 50 or older at average risk should, as one of their screening options, be screened annually with an FOBT or FIT for this disease. Rec
'/>"/>

SOURCE Quest Diagnostics Incorporated Copyright©2008 PR Newswire. All rights reserved

0 GOOD

Page: 1 2 3 4
Related biology technology :

1. ImmuneRegen Responds to Defense Threat Reduction Agency Request for Information
2. NovaQuest Advances Virtual Development Model With Strategic Investment in TOPIGEN Pharmaceuticals
3. Quest Diagnostics to Speak at the 2007 UBS Global Life Sciences Conference
4. VioQuest Pharmaceuticals to Present at BIO InvestorForum in San Francisco
5. Quest Diagnostics Joins National ePrescribing Patient Safety Initiative (NEPSI)
6. University HealthSystem Consortium Chooses SciQuest to Optimize Medical Research Procurement
7. VioQuest Pharmaceuticals to Present at the Paramount BioSciences Healthcare Conference
8. Sinovac Requests Extension for Annual Shareholders Meeting
9. Maryland Stem Cell Commission Issues Nationwide Request for Applications for New Post-Doctoral Fellowship Grants
10. AmSurg Selects SciQuest Eprocurement Solution to Automate Purchasing of Medical Goods and Services
11. Quest PharmaTech to Receive $3,000,000 to Develop Oncology Products Based on its SonoLight Technology